Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 2/20 | 0.60 |
| ▸ | CCR5 | P51681 | 2/20 | 0.60 |
| ▸ | CCR8 | P51685 | 2/20 | 0.60 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.60 |
| ▸ | METAP2 | P50579 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.42 |
| ▸ | NOS3 | P29474 | 2/20 | 0.40 |
| ▸ | NOS2 | P35228 | 2/20 | 0.40 |
| ▸ | MERTK | Q12866 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.37 |
| ▸ | RELA | Q04206 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21266019 | 0.83 | CCR1 (0.50) | CCR1CCR5CCR8HDAC6METAP2 | |
| SCHEMBL24066438 | 0.83 | CCR1 (0.60) | CCR1CCR5CCR8HDAC6METAP2 | |
| SCHEMBL18814932 | 0.83 | CCR1 (0.60) | CCR1CCR5CCR8HDAC6METAP2 | |
| SCHEMBL24395066 | 0.82 | CCR1 (0.48) | CCR1CCR5CCR8HDAC6METAP2 | |
| SCHEMBL1923831 | 0.77 | CCR1 (0.52) | CCR1CCR5CCR8HDAC6METAP2 | |
| SCHEMBL23667868 | 0.77 | CCR1 (0.52) | CCR1CCR5CCR8HDAC6METAP2 | |
| SCHEMBL23339298 | 0.77 | CCR1 (0.62) | CCR1CCR5CCR8HDAC6METAP2 | |
| SCHEMBL13515206 | 0.77 | CCR1 (0.70) | CCR1CCR5CCR8HDAC6METAP2 | |
| Abametapir SCHEMBL351152 | 0.77 | CCR1 (1.00) | CCR1CCR5CCR8HDAC6METAP2 | |
| Abametapir SCHEMBL29374261 | 0.77 | CCR1 (1.00) | CCR1CCR5CCR8HDAC6METAP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230006151-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-01-05 | — | — | US | disclosed |
| US-10651403-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230006151-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | L1CAM, EPCAM, LEF1 | CCR1 1841/4885CCR5 1531/4885CCR8 3242/4885 |
| US-10651403-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, JUND | CCR1 4293/4885CCR5 2533/4885CCR8 3791/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.